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Objective  To ascertain the etiology of non-traumatic plexopathy and clarify the clinical, electrophysiological 
characteristics according to its etiology.
Method  We performed a retrospective analysis of 63 non-traumatic plexopathy patients that had been diagnosed 
by nerve conduction studies (NCS) and needle electromyography (EMG). Clinical, electrophysiological, imaging 
fi  ndings were obtained from medical records.
Results  We identifi  ed 36 cases with brachial plexopathy (BP) and 27 cases with lumbosacral plexopathy (LSP). 
The causes of plexopathy were neoplastic (36.1%), thoracic outlet syndrome (TOS) (25.0%), radiation induced 
(16.7%), neuralgic amyotrophy (8.3%), perioperative (5.6%), unknown (8.3%) in BP, while neoplastic (59.3%), 
radiation induced (22.2%), neuralgic amyotrophy (7.4%), psoas muscle abscess (3.7%), and unknown (7.4%) in 
LSP. In neoplastic plexopathy, pain presented as the fi  rst symptom in most patients (82.8%), with the lower trunk 
of the brachial plexus predominantly involved. In radiation induced plexopathy (RIP), pain was a common initial 
symptom, but the proportion was smaller (50%), and predominant involvements of bilateral lumbosacral plexus 
and whole trunk of brachial or lumbosacral plexus were characteristic. Myokymic discharges were noted in 41.7% 
patients with RIP. Abnormal NCS fi  nding in the medial antebrachial cutaneous nerve was the most sensitive to 
diagnose TOS. Neuralgic amyotrophy of the brachial plexus showed upper trunk involvement in all cases.
Conclusion  By integrating anatomic, pathophysiologic knowledge with detailed clinical assessment and the 
results of ancillary studies, physicians can make an accurate diagnosis and prognosis.
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INTRODUCTION
  Common conditions of the peripheral nervous system 
disorders are entrapment neuropathy, radiculopathy, 
and peripheral polyneuropathy. However, brachial 
plexopathy (BP) and lumbosacral plexopathy (LSP), are 
relatively uncommon.
1 BP accounts for approximately 
14% of all isolated upper limb neurologic lesions,
2 and 
LSP accounts for a smaller percent of isolated lower limb Kiljun Ko, et al.
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neurologic lesions.
  The nerve fibers passing through the plexus can be 
injured by various mechanisms such as laceration, 
compression, traction, stretch, radiation, and ischemia.
3 
By the nature of plexus injury, traumatic plexopathy is 
the most common, and there are many other causes 
such as neoplastic, radiation induced, perioperative, 
neuralgic amyotrophy, thoracic outlet syndrome (TOS), 
infectious, and diabetic conditions.
3,4 In case of negative 
history of trauma, it is important to clarify the underlying 
etiology since signifi  cant diff  erences occur in diagnostic 
approach, treatment plan, and prognosis.
  We identified the causes of non-traumatic plexo-
pathy in adult patients, and clarified the clinical, 
electrophysiological characteristics, and imaging fi  ndings 
according to its etiology.
MATERIALS AND METHODS
  We analyzed the medical records, electrophysiological, 
and imaging findings of patients with non-traumatic 
plexopathy who were 20 years old or above and who had 
undergone nerve conduction studies (NCS) and needle 
electromyography (EMG) at our electrophysiological 
laboratory between January 1999 and January 2010. 
The diagnosis of plexopathy was confirmed using the 
following criteria: 1) abnormal NCS fi  ndings conforming 
to the anatomical distribution of the plexus when 
compared with our normative values, or a difference 
more than 50% in amplitude of nerve action potentials 
between the symptomatic and asymptomatic side when 
normative values were not available in certain nerves, 
such as musculocutaneous, axillary, suprascapular, 
radial, superficial radial, femoral, lateral femoral 
cutaneous, and saphenous nerve, and 2) evidence 
of denervation potentials or neuropathic potentials 
conforming to the anatomical distribution of the plexus 
in needle EMG, and 3) no evidence of denervation 
potentials in paraspinal muscles, and 4) no evidence 
of cervical or lumbosacral radiculopathy in magnetic 
resonance imaging (MRI) of the spine.
  We excluded cases where a clear history of trauma was 
directly related to plexus injury, such as traffi   c accident, 
falls, and associated with medical procedure or surgery, 
and we classified plexopathy based on the nature of 
injury.
3,4
  The causes of non-traumatic plexopathy were defined 
as follows. In patients with a history of cancer, the 
diagnosis of neoplastic plexopathy was confirmed by 
imaging findings, which showed direct invasion of the 
plexus by cancer or compressive lesion by metastatic 
enlarged lymph nodes or soft tissues. In patients 
without a history of cancer, the diagnosis of neoplastic 
plexopathy was made by confirming histopathologic 
findings. Radiation induced plexopathy (RIP) was 
defined as cases with a history of radiation therapy, 
but without evidence of recurrent tumor or metastatic 
invasion by imaging findings. TOS was defined as 
follows: 1) sensory symptoms in the medial forearm and 
fourth-fifth finger; 2) objective sign of sensory loss in 
medial antebrachial cutaneous (MABC) or ulnar nerve 
areas; 3) electrophysiological findings corresponding 
to lower trunk lesion, but no evidence of carpal tunnel 
syndrome, ulnar neuropathy, or cervical radiculopathy, 
and 4) Imaging findings suggesting the diagnosis of 
TOS: presence of either elongated transverse process 
or cervical rib on plain radiography, or evidence of 
compression of neurovascular bundle at thoracic outlet 
on either computed tomography (CT) angiography 
or brachial plexus MRI. Neuralgic amyotrophy was 
defined as cases that had a history of sudden onset of 
severe pain at unilateral upper or lower limb, followed 
by weakness and/or muscle atrophy with the exclusion 
of other possible causes of plexopathy. We excluded 
cases showing a pattern of mononeuropathy, such 
as long thoracic mononeuropathy, or suprascapular 
mononeuropathy on electrophysiological findings, and 
thus, we included cases which showed a plexopathy 
pattern. Perioperative plexopathy was defined as cases 
with an onset after surgery, but without evidence of 
direct trauma though the surgical procedure, as well as 
exposure of the plexus to the surgical fi  eld.
RESULTS
  Thirty six patients (mean age, 49.3±11.9 years; male 
to female ratio, 14 : 22) with BP, and 27 patients (mean 
age, 52.7±13.7 years; male to female ratio, 6 : 21) with 
LSP were identified. The causes of BP included 13 
patients (36.1%) with neoplastic plexopathy, 9 patients 
(25.0%) with TOS, 6 patients (16.7%) with RIP, 3 patients 
(8.3%) with neuralgic amyotrohy, 2 patients (5.6%) with Clinical, Electrophysiological Findings in Non-traumatic Plexopathies
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perioperative, and 3 patients (8.3%) of unknown cause. 
The causes of LSP included 16 patients (59.3%) with 
neoplastic plexopathy, 6 patients (22.2%) with RIP, 2 
patients (7.4%) with neuralgic amyotrophy, one patient 
(3.7%) with psoas muscle abscess, 2 patients (7.4%) with 
unknown cause (Table 1).
Brachial plexus lesions
  Neoplastic brachial plexopathy (N=13): There were 5 
males and 8 females with the mean age of 52.9±11.3 years. 
Of the 7 patients (53.8%) who had a previous diagnosis 
of cancer, 5 were undergoing cancer therapy, and 2 had 
recurrent after cancer therapy. Six patients (56.2%) who 
had no history of cancer, encountered the diagnosis of 
primary cancer due to neoplastic BP. Secondary plexus 
tumors accounted for 84.6% (n=11) of neoplastic BP, 
composed of 3 breast cancers, 3 lung cancers, 2 diffuse 
large B cell lymphomas, one thyroid cancer, one desmoid 
tumor, and one chloroma (extramedullary myeloid 
tumor). Two cases (15.4%) were due to primary brachial 
plexus tumor, one schwannoma and one malignant 
peripheral nerve sheath tumor (Table 2) (Fig. 1-A). 
  Initial clinical manifestations were pain (n=9), pain and 
weakness (n=1), weakness (n=1), and palpable neck mass 
(n=1). Physical examination revealed sensory loss (n=11), 
weakness (n=11), Horner syndrome (n=3), and upper 
limb edema (n=1).
  NCS and needle EMG demonstrated that all patients had 
a unilateral lesion, and frequency of location was higher 
in lower trunk/medial cord lesion (n=7) and whole 
plexus lesion (n=5) than in upper trunk/lateral cord 
lesion (n=1). Based on imaging fi  ndings, supraclavicular, 
infraclavicular, and whole plexus lesions were noted in 3, 
5, and 5 cases respectively. One case with acute myeloid 
Table 1. Causes of Non-traumatic Plexopathy (N=63)
Plexus location Cause Cases number (%) Mean age, years Gender, M : F
Brachial plexus (N=36) Neoplastic 13 (36.1) 52.9 5 : 8
Th   oracic outlet syndrome  9 (25.0) 48.7 2 : 7
Radiation  6 (16.7) 45.2 1 : 5
Neuralgic amyotrophy 3 (8.3) 47.7 2 : 1
Perioperative  2 (5.6) 42.5 2 : 0
Unknown  3 (8.3) 50.3 2 : 1
Lumbosacral plexus (N=27) Neoplastic 16 (59.3) 51.8   3 : 13
Radiation 6 (22.2) 61.0 0 : 6
Neuralgic amyotrophy  2 (7.4) 46.5 2 : 0
Psoas muscle abscess  1 (3.7) 68.0 0 : 1
Unknown  2 (7.4) 35.5 0 : 2
Table 2. Neoplastic Plexopathy Neoplasm by Location (N=29)
Brachial plexus (N=13) Lumbosacral plexus (N=16)
Tumor No. Tumor No.
  Lung 3 Uterine cervix 7
  Breast 3 Sarcoma 3
  Diff  use large B cell lymphoma 2 Colorectal 2
  Th  yroid 1 Bladder 1
  Schwannoma*
† 1 Vulvar 1
  Desmoid tumor
† 1 Nasopharynx 1
  Malignant peripheral nerve sheath tumor* 1 Malignant peripheral nerve sheath tumor* 1
  Chloroma 1
*Primary plexus tumors, 
†Benign tumorsKiljun Ko, et al.
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leukemia did not show compressive lesion but direct 
perineural spread (Fig. 1-B, C).
  Radiation induced brachial plexopathy (N=6): There 
were one male and 5 females with the mean age of 
45.2±9.2 years. Underlying tumors included 2 breast 
cancers, 2 nasopharyngeal cancers, one thyroid cancer, 
and one fibromatosis. Mean interval between radiation 
and onset of symptom was 2.9±3.7 years (median 
interval, 4.25 years; range, 3 months to 7 years).
  Initial clinical manifestations were weakness (n=2), 
weakness and pain (n=1), pain (n=1), numbness (n=1), 
and limitation of shoulder range of motion (n=1). 
Physical examination revealed sensory loss (n=4), 
weakness (n=4), upper limb edema (n=1), and no Horner 
Fig. 1. (A) PET-CT in a patient with 
malignant peripheral nerve sheath 
tumor (arrow) in right brachial 
plexus. Histopathologic confi  rmation 
was malignant transformation 
originating from neurofibroma. (B, 
C) Brachial plexus MRI and PET-
CT in a patient with chloroma. 
Brachial plexus MRI shows diffuse 
enhancement and swelling (arrow) 
in brachial plexus from trunk to cord 
level which suggests peri-plexus 
infi  ltration of chloroma.
Table 3. Comparison of Clinical, Electrophysiological Characteristics between Neoplastic and Radiation Induced 
Plexopathy (N=41)
Neoplastic plexopathy
(N=29)
Radiation plexopathy
(N=12)
No. Percent Ratio No. Percent Ratio
  First presenting symptom Pain
Weakness
Limb edema
Palpable mass
24
5
5
1
82.8
17.2
17.2
3.4
6
4
0
50.0
33.3
0
  Findings of physical examinationSensory loss
Motor weakness
Limb edema
26
25
8
89.7
86.2
27.6
8
10
3
66.7
83.3
25.0
  Laterality (unilateral : bilateral) Brachial 13 : 0 6 : 0
Lumbosacral 15 : 1 1 : 5
  Brachial plexus lesion Upper trunk/lateral cord
Lower trunk/medial cord
Whole
1
7
5
7.7
53.8
38.5
2
0
4
33.3
0
66.7
  Lumbosacral plexus lesion Lumbar (L1-L4)
Sacral (L5-S3)
Whole (L1-S3)
2
6
8
12.5
37.5
50
0
2
4
0
33.3
66.7
  Myokymic discharge 0 0 5 41.7Clinical, Electrophysiological Findings in Non-traumatic Plexopathies
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syndrome. 
  NCS and needle EMG demonstrated that all patients had 
a unilateral lesion. Th   e most common location was whole 
plexus lesion (n=4), followed by upper trunk/lateral cord 
lesion (n=2), and there was no lower trunk/medial cord 
lesion (Table 3). Myokymic discharges which suggest RIP 
were detected in 2 patients (33.3%). Brachial plexus MRI 
of one patient demonstrated the fi  brosis of tissues around 
the plexus (Fig. 2-A, B).
  Thoracic outlet syndrome (N=9): 7 patients were 
females with the mean age of 48.7±16.5 years. All patients 
had a unilateral lesion. Physical examination showed 
thenar atrophy in 6 patients, and muscle weakness in 
8 patients. All patients showed grade 4-4+ of abductor 
pollicis brevis on Medical Research Council scale, and 
2 patients showed grade 4+ of abductor digiti minimi 
and fi  rst dorsal interossei. Positive fi  nding was noted in 
3 patients with Adson test, 2 with Wright test, one with 
90 degree abduction-external rotation test, and one with 
upper limb tension test.
  Of 8 patients (88.9%) who showed abnormal findings 
on plain radiography, 5 had elongated transverse 
process, 2 had cervical rib, and one had both. Of 3 
patients who underwent Brachial plexus MRI, one had 
an evidence of compression of neurovascular bundle. 
Electrophysiological findings were consistent with a 
lesion affecting lower trunk of brachial plexus. NCS 
were conducted in 7 patients of MABC nerves, and in all 
patients of median and ulnar nerves. Abnormal fi  ndings 
were noted in MABC sensory nerve action potential 
(SNAP), ulnar SNAP, median compound muscle action 
potential (CMAP), and ulnar CMAP: 85.7%, 77.8%, 
55.6%, and 33.3% respectively. Denervation potentials on 
needle EMG were noted in 8 patients. Muscles observed 
denervation potentials included abductor pollicis brevis 
(n=5), abductor digiti minimi (n=3), fi  rst dorsal interossei 
(n=3), flexor digitorum profundus (n=1), and extensor 
indicis proprius (n=1).
  Neuralgic amyotrophy of brachial plexus (N=3): Th  ere 
were 2 males and one female. Age was 34, 49, and 60 years 
respectively. 2 patients showed left side involvement and 
one right side involvement. Interval between onset of 
pain and development of weakness was 1, 2, and 7 days 
respectively. All patients showed grade 1-2 of shoulder 
flexors and abductors, and grade 3-4 of elbow flexors. 
Elbow extensors, wrist extensors, wrist flexors, hand 
Fig. 2. Brachial plexus MRI in a pa-
tient with radiation induced brachial 
plexopathy (A, B). Images show 
signal change and enhancement 
in brachial plexus [arrow, A], and 
fi  brosis in subscapularis, teres minor, 
pectoralis, and infraclavicular soft 
tissue [arrow, B] which suggest 
radiation induced fi  brosis. (C) Pelvis 
CT demonstrates osteosclerotic 
cystic lesions (arrow) in right ilium 
which suggest association with 
radiation. (D) Pelvis X ray shows 
dense radiopacity lesions (arrow) in 
both ilia which suggest osteonecrosis.Kiljun Ko, et al.
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intrinsic muscles showed normal grade. Sensory tests 
were normal and Spurling sign was negative.
  Abnormal NCS findings were noted in axillary nerve 
(n=3), musculocutaneous nerve (n=2), suprascapular 
nerve (n=1), and lateral antebrachial cutaneous nerve 
(n=1). Denervation potentials were detected in muscles 
innervated by suprascapular (n=2), musculocutaneous 
(n=2), and axillary nerve (n=2). Neuropathic potentials 
were detected in muscles innervated by suprascapular 
(n=1), musculocutaneous (n=1). Electrophysiological 
findings were consistent with a lesion affecting upper 
trunk of brachial plexus.
  Perioperative brachial plexopathy (N=2): There were 
one case with median sternotomy and one case with 
subtotal gastrectomy. Patient with median sternotomy 
showed grade 1 of hand intrinsic muscles while 
normal grade of shoulder, elbow, wrist joint muscles. 
Electrophysiological fi  ndings were compatible with lower 
trunk lesion.
  Patient with subtotal gastrectomy showed grade 4 
of shoulder abductors and elbow flexors. Electro-
physiological fi  ndings were compatible with upper trunk 
lesion.
Lumbosacral plexus lesions
  Neoplastic lumboscral plexopathy (N=16): Th  ere  were 
3 males and 13 females with the mean age of 51.7±13.9 
years. Predominance of female was observed. 13 patients 
(81.3%) had a previous diagnosis of cancer, 3 patients 
(18.7%) who had no history of cancer, were diagnosed 
with underlying primary tumor due to neoplastic LSP. 
Secondary plexus tumors accounted for 93.8% (n=15) of 
neoplastic LSP, while primary plexus tumors accounted 
for 6.2% (n=1). Secondary plexus tumors included 7 
uterine cervix cancers (43.8%), 3 sarcomas, 2 colorectal 
cancers, one bladder cancer, one vulvar cancer, and one 
nasopharyngeal cancer (Table 2).
  Initial clinical manifestations were pain (n=11), pain 
and limb edema (n=2), pain and weakness (n=1), and 
weakness and limb edema (n=2). Pain was the most 
predominant initial symptom as in neoplastic BP. 
Physical examination revealed sensory loss (n=15), 
weakness (n=14), and lower limb edema (n=7).
  NCS and needle EMG demonstrated that 15 patients 
(93.8%) had a unilateral lesion, one patient (6.2%) with 
uterine cervix cancer had a bilateral lesion. The most 
common location was whole plexus (L1-S3) lesion (n=8), 
followed by sacral plexus (L5-S3) lesion (n=6), and 
lumbar plexus (L1-L4) lesion (n=2).
  Radiation induced lumbosacral plexopathy (N=6): 
All patients were females with the mean age of 61.0±9.1 
years. Underlying tumors included 5 uterine cervix 
cancers, and one colorectal cancer. Mean interval 
between radiation and onset of symptom was 7.8±8.8 
years (median interval, 6.5 years; range, 3 months 
to 24 years). Initial clinical manifestations were pain 
(n=4), paresthesia (n=1), and weakness (n=1). Physical 
examination revealed weakness (n=6), sensory loss (n=4), 
and lower limb edema (n=2). 
  NCS and needle EMG demonstrated that 5 patients 
(83.3%) had a bilateral lesion, and one patient (16.7%) 
had a unilateral lesion. Th   e most common location was 
whole plexus lesion (n=4), followed by sacral plexus 
lesion (n=2), and there was no lumbar plexus lesion 
(Table 3). Myokymic discharges were detected in 3 
patients (50%). Two patients showed osteonecrosis 
in illium by pelvis X-ray and CT (Fig. 2-C, D), which 
suggested association with RIP.
  Neuralgic amyotrophy of lumbosacral plexus (N=2): 
Both patients showed unilateral involvement, one with 
left side and one with right side. The interval between 
onset of pain and development of weakness was several 
hours and 2 weeks respectively. Physical examination 
revealed sensory loss in one patient, and weakness in 2 
patients. A 37-year-old man showed grade 4+ of muscles 
innervated by lumbar plexus, and a 53-year-old man 
showed grade 3-4 of muscles innervated by lumbar plexus 
and lumbosacral trunk (L2-L5). Electrophysiological 
findings were consistent with lumbar plexus lesion in a 
37-year-old man, and lumbosacral plexus lesion 53-year-
old man.
DISCUSSION
 
  Neoplastic plexopathy can be divided into primary 
or secondary. While primary plexus tumors are rare 
and usually benign, secondary plexus tumors are the 
most common and all types are malignant. Secondary 
plexus tumors involve the plexus by means of extrinsic 
compression or infiltration from adjacent structures or 
spread from distant metastasis.
5,6
  In this study, there were two cases of primary malignant Clinical, Electrophysiological Findings in Non-traumatic Plexopathies
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tumors. Th   e histopathology revealed that both cases had 
undergone malignant transformation from plexiform 
neurofi  broma in patients with neurofi  bromatosis type 1 
(NF1). Most primary malignant tumors originate from 
plexiform neurofibroma,
7 and approximately 5-10% of 
patients with NF1 develop malignant change, usually 
in a preexisting plexiform neurofibroma.
8 Secondary 
plexus tumors develop late in the course of the disease.
9 
The most common tumors reported are lung cancer, 
breast cancer, and lymphoma in BP,
10 and colorectal 
cancer, sarcoma, uterine cervix cancer, and lymphoma 
in LSP.
11 Our results showed that the percent of uterine 
cervical cancer was higher than previously reported. Th  e 
high prevalence of uterine cervical cancer in Korea may 
contribute to this fi  nding.
  It is known that neoplastic plexopathy generally begins 
with pain, followed by sensory loss and weakness, and 
that pain is the most common presenting symptom (75-
98%);
10-13 our results were similar to these clinical fi  ndings 
(Table 3). Limb edema was relatively infrequent in BP, 
(7.7%) but was more commonly seen in LSP (43.8%), and 
this fi  nding was similar to previous studies.
10,11,13 For the 
purpose of comparing the clinical differences between 
neoplastic plexopathy and RIP, we described BP and LSP 
together (Table 3). Brachial and lumbosacral plexus, 
however, are distinctly different anatomical structures. 
The brachial plexus, originating from ventral primary 
rami of the lower 4 cervical and the first thoracic roots 
(C5-T1), is the most complex structure, and supplies most 
of the upper extremity and shoulder.
6 The lumbosacral 
plexus is composed of 2 plexus, lumbar and sacral plexus, 
originating from ventral primary rami of the 5 lumbar 
and the fi  rst 3 sacral roots (L1-5 and S1-3), and supplies 
the lower extremity.
4
  Generally, plexopathies are classified according to the 
region involved, such as supraclavicular, infraclavicular, 
and whole plexus lesions. The supraclavicular plexus is 
further divided into upper (C5 and C6 roots and upper 
trunk), middle (C7 root and middle trunk), and lower 
(C8 and T1 roots and lower trunk) portions, and the 
infraclavicular plexus is further divided into 3 cords 
(medial, lateral, and posterior cords), and their terminal 
branches.
6 This classification system, however, was 
not used in this study. In some cases, it was difficult to 
localize the lesion as NCS and needle EMG had not been 
performed suffi   ciently. Th   is is a limitation of retrospective 
study. In another cases, it was also difficult to localize 
the lesion, although NCS and needle EMG had been 
performed sufficiently. This is a limitation of NCS and 
needle EMG. We classifi  ed the plexus lesions in 3 groups, 
upper trunk/lateral cord, lower trunk/medial cord, 
and whole plexus lesion based on electrophysiological 
findings. According to this classification, different 
patterns of involvement were noted among underlying 
etiologies, so it is possible to determine their clinical 
characteristics.
  Our results revealed that frequency of location of 
neoplastic BP was higher in lower trunk/medial cord 
and whole plexus lesion and that of neoplastic LSP was 
higher in sacral plexus lesion and bilateral lesion. This 
finding suggests that invasion of the brachial plexus 
is characterized by superior extension of lung cancer 
(“Pancoast” syndrome or superior sulcus tumor) or 
breast cancer,
14 and that of the lumbosacral plexus 
by direct local extension of uterine cervical cancer or 
colorectal cancer within the pelvis.
11,12
  RIP typically presents as a painless lesion with 
paresthesia and numbness, and lesion of the lumbosacral 
plexus is associated with limb edema and bilateral 
involvement.
13,15-17 In contrast to previous reports, our 
results showed that the rate of pain presenting with 
the first symptom was 50% (Table 3), which was higher 
than previous reports, and the development of limb 
edema was not significantly different between RIP and 
neoplastic plexopathy. The small sample size and the 
limitations of a retrospective study may contribute to 
these results. Further study with a large sample size is 
needed for more conclusive results. Myokymic discharges 
were detected in 5 of 12 patients (41.7%) with RIP. Several 
studies reported that approximately 60% of patients 
with RIP show myokymic discharges on needle EMG,
18,19 
which is quite unusual with neoplastic plexopathy.
  True neurogenic TOS demonstrates physical and 
electrophysiological findings consistent with a lesion 
affecting the C8/T1 roots or lower trunk of brachial 
plexus.
20 Provocation maneuvers, such as Adson test, 
Wright test, 90-degree abduction-external rotation 
test, and upper limb tension test, are implemented 
to diagnose TOS, although they have a low specificity 
with a false-positive rate of 11% in Adson test, 62% 
in 90-degree abduction-external rotation test.
21 NCS 
typically demonstrate reduced amplitude in median Kiljun Ko, et al.
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CMAP and ulnar SNAP, reduced or normal amplitude in 
ulnar CMAP, and normal median SNAP. Recent studies 
reported that reduced amplitude in MABC SNAP was the 
most sensitive test to diagnose TOS.
22-25 Our results were 
consistent with these findings, therefore NCS of MABC 
nerve should be conducted when neurogenic TOS was 
suspected.
  Classic postoperative paralysis, considered to develop 
due to traction and compression by surgical position 
or supporting brace, has a full recovery course by 3-4 
months.
6,26 Etiology of post-median sternotomy BP, 
commonly accepted, is a traction or compression 
secondary to rotation of the first rib with excessive 
retraction of the rib cage.
20,27 The distinction between 
TOS and post-median sternotomy is needed since they 
present symptoms and signs of C8/T1 roots. Patients with 
post-median sternotomy have C8 fibers preferentially 
affected at the root level while patients with TOS have 
T1 fibers disrupted at the upper trunk level. In contrast 
to TOS, post-median sternotomy demonstrate that the 
MABC SNAP and median CMAP are less severely aff  ected 
than the ulnar SNAP and CMAP.
  Neuralgic amyotrophy is characterized by acute onset of 
severe pain associated with multifocal muscle weakness 
and subsequent atrophy that usually appears as the pain 
lessens.
28 Although the most common, typical phenotype 
of an attack involves the upper and middle trunk of the 
brachial plexus, including long thoracic nerve, some 
cases involve the lumbosacral plexus and lower cranial 
nerves.
28-32 It is likely that, rather than a single disease 
entity, neuralgic amyotrophy is a syndrome comprising 
different underlying mechanisms, phenotypes and 
prognoses.
33 
  The limitations of our study include that the small 
sample size and that it was conducted retrospectively. In 
order to clarify etiology and frequency of non-traumatic 
plexopathy, and to compare with previous reports, more 
and larger sized multicenter study may be necessary.
CONCLUSION
  Th   e most common etiology of non-traumatic plexopathy 
in adult patients was neoplastic plexopathy, which 
almost always originated from secondary plexus tumors. 
Since the rate of history of cancer was low in patients 
with neoplastic BP, we should not overlook the possibility 
of neoplasm when BP is suspected.
  Clinical distinctions of neoplastic plexopathy from 
RIP were that most patients with neoplastic plexopathy 
presented with pain as the first symptom, and the 
proportion of patients with pain as the fi  rst symptom was 
higher than in patients with RIP. Neoplastic plexopathy 
showed unilateral lumbosacral lesion, while RIP showed 
bilateral lumbosacral lesion. Electrophysiological 
findings demonstrated that lower trunk/medial cord 
lesion was predominantly involved in neoplastic BP, 
while whole plexus lesion was more involved in radiation 
induced BP. TOS involves C8 and T1 roots or lower trunk 
of brachial plexus, but it preferentially affects T1 fibers. 
MABC SNAP was the most sensitive diagnose TOS.
  By the acquisition of clinical and electrophysiological 
findings according to etiology, physicians can make an 
accurate diagnosis and prognosis.
REFERENCES
1.  Dumitru D. Electrodiagnostic medicine, 2nd ed, 
Philadelphia, Hanley & Belfus, 2002, 785-814
2.  Mumenthaler M. Some clinical aspects of peripheral 
nerve lesions. Eur Neurol 1969; 2: 257-268
3.  Wilbourn AJ. Brachial plexus disorders. In: Th  onas  PK, 
Editor. Peripheral neuropathy, 3rd ed, Philadelphia, 
WB Saunders, 1993, 911-950
4.  Dumitru D. Electrodiagnostic medicine, 2nd ed, 
Philadelphia, Hanley & Belfus, 2002, 837-875
5.  Das S, Ganju A, Tiel RL, Kline DG. Tumors of the 
brachial plexus. Neurosurg Focus 2007; 22: E26
6.  Ferrante MA. Brachial plexopathies: classification, 
causes, and consequences. Muscle Nerve 2004; 30: 
547-568
7.  Park JK. Peripheral nerve tumors. In: Samuels MA, 
Feske SK, Editors. Office practice of neurology, 2nd 
ed, Philadelphia, Churchill Livingstone, 2003, 1118-
1121
8.  Pacelli J, Whitaker CH. Brachial plexopathy due 
to malignant peripheral nerve sheath tumor in 
neurofibromatosis type 1: case report and subject 
review. Muscle Nerve 2006; 33: 697-700
9.  Kamenova B, Braverman AS, Schwartz M, Sohn 
C, Lange C, Efiom-Ekaha D, Rotman M, Yoon H. 
Eff  ective treatment of the brachial plexus syndrome in 
breast cancer patients by early detection and control Clinical, Electrophysiological Findings in Non-traumatic Plexopathies
815 www.e-arm.org
of loco-regional metastases with radiation or systemic 
therapy. Int J Clin Oncol 2009; 14: 219-224
10. Kori SH, Foley KM, Posner JB. Brachial plexus lesions 
in patients with cancer: 100 cases. Neurology 1981; 31: 
45-50
11. Jaeckle KA, Young DF, Foley KM. Th   e natural history 
of lumbosacral plexopathy in cancer. Neurology 1985; 
35: 8-15
12. Briemberg HR, Amato AA. Neuromuscular com-
plications of cancer. Neurol Clin 2003; 21: 141-165
13. Jaeckle KA. Neurologic manifestations of neoplastic 
and radiation-induced plexopathies. Semin Neurol 
2010; 30: 254-262
14. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish 
GW, Munden RF, Erasmus JJ. Imaging of non-
small cell lung cancer of the superior sulcus: part 1: 
anatomy, clinical manifestations, and management. 
Radiographics 2008; 28: 551-560
15. Basso-Ricci S, della Costa C, Viganotti G, Ventafridda 
V, Zanolla R. Report on 42 cases of postirradiation 
lesions of the brachial plexus and their treatment. 
Tumori 1980; 66: 117-122
16. Mondrup K, Olsen NK, Pfeiff  er P, Rose C. Clinical and 
electrodiagnostic findings in breast cancer patients 
with radiation-induced brachial plexus neuropathy. 
Acta Neurol Scand 1990; 81: 153-158
17. Olsen NK, Pfeiff  er P, Johannsen L, Schroder H, Rose C. 
Radiation-induced brachial plexopathy: neurological 
follow-up in 161 recurrence-free breast cancer 
patients. Int J Radiat Oncol Biol Phys 1993; 26: 43-49
18. Harper CM Jr, Thomas JE, Cascino TL, Litchy WJ. 
Distinction between neoplastic and radiation-
induced brachial plexopathy, with emphasis on the 
role of EMG. Neurology 1989; 39: 502-506
19.  Roth G, Magistris MR, Le Fort D, Desjacques P, 
Della Santa D. Post-radiation branchial plexopathy. 
Persistent conduction block. Myokymic discharges 
and cramps. Rev Neurol (Paris) 1988; 144: 173-180
20. Dumitru D. Electrodiagnostic medicine, 2nd ed, Phi-
ladelphia, Hanley & Belfus, 2002, 818-820
21. Plewa MC, Delinger M. The false-positive rate of 
thoracic outlet syndrome shoulder maneuvers in 
healthy subjects. Acad Emerg Med 1998; 5: 337-342
22. Kothari MJ, Macintosh K, Heistand M, Logigian EL. 
Medial antebrachial cutaneous sensory studies in the 
evaluation of neurogenic thoracic outlet syndrome. 
Muscle Nerve 1998; 21: 647-649
23. Levin KH, Wilbourn AJ, Maggiano HJ. Cervical rib and 
median sternotomy-related brachial plexopathies : a 
reassessment. Neurology 1998; 50: 1407-1413
24. Machanic BI, Sanders RJ. Medial antebrachial cuta-
neous nerve measurements to diagnose neurogenic 
thoracic outlet syndrome. Ann Vasc Surg 2008; 22: 
248-254
25.  Seror P. Medial antebrachial cutaneous nerve 
conduction study, a new tool to demonstrate mild 
lower brachial plexus lesions. A report of 16 cases. 
Clin Neurophysiol 2004; 115: 2316-2322
26. Cooper DE, Jenkins RS, Bready L, Rockwood CA 
Jr. The prevention of injuries of the brachial plexus 
secondary to malposition of the patient during 
surgery. Clin Orthop Relat Res 1988; 228: 33-41
27. Kirsh MM, Magee KR, Gago O, Kahn DR, Sloan H. 
Brachial plexus injury following median sternotomy 
incision. Ann Th   orac Surg 1971; 11: 315-319
28. van Alfen N. Th   e neuralgic amyotrophy consultation. J 
Neurol 2007; 254: 695-704
29. Awerbuch GI, Nigro MA, Sandyk R, Levin JR. Relap-
sing lumbosacral plexus neuropathy. Report of two 
cases. Eur Neurol 1991; 31: 348-351
30. Evans BA, Stevens JC, Dyck PJ. Lumbosacral plexus 
neuropathy. Neurology 1981; 31: 1327-1330
31. Sander JE, Sharp FR. Lumbosacral plexus neuritis. 
Neurology 1981; 31: 470-473
32. Yee T. Recurrent idiopathic lumbosacral plexopathy. 
Muscle Nerve 2000; 23: 1439-1442
33. van Alfen N, van Engelen BG. Th   e clinical spectrum of 
neuralgic amyotrophy in 246 cases. Brain 2006; 129: 
438-450